PAE to Mobilize Georgia World Congress Center as Alternate Care Site for COVID-19 Response
Falls Church, Va., April 13, 2020 (GLOBE NEWSWIRE) — PAE (NASDAQ: PAE, PAEWW), a global leader in delivering smart solutions […]
Eloxx Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Business Update on May 7, 2020
WALTHAM, Mass., April 13, 2020 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the […]
Consulting Magazine Names FTI Consulting’s Jordan Rae Kelly to Women Leaders in Technology List
WASHINGTON, April 13, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that Consulting magazine has named Jordan […]
TSX News -
SouthGobi announces deferral of CIC payment obligation
VANCOUVER, British Columbia, April 13, 2020 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) […]
Burlington Stores, Inc. Announces Proposed Offering of Senior Secured Notes
BURLINGTON, N.J., April 13, 2020 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL) (the “Company”) announced today that its indirect […]
Burlington Stores, Inc. Announces Proposed Offering of Convertible Senior Notes
BURLINGTON, N.J., April 13, 2020 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL) (the “Company”) announced today that it has […]
Fennec Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of New Drug Application for PEDMARK™
~ Potential for PEDMARK to be the First Product for the Prevention of Cisplatin-Induced Hearing Loss in Children ~~ FDA […]
Sol-Gel Technologies Announces Closing of Additional $5.0 Million Investment
Investment is for ordinary shares and warrants to purchase ordinary shares at a combined price of $11 per ordinary share […]
NextCure Provides Update on Clinical Trial Activities Due to Impact of COVID-19 Pandemic
BELTSVILLE, Md., April 13, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]
Fulcrum Therapeutics Announces Completion of IND-enabling Safety Studies for FTX-6058 in Sickle Cell Disease
CAMBRIDGE, Mass., April 13, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives […]
